N
NewAmsterdam Pharma Company N.V. (NAMS)
29.98
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
29.98
0.00 (0.00%)
This stock has a consensus price target of $44.08 based on the ratings of 14 analysts. The high is $52.00 and the low is $22.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 22 | $ 44.08 | $ 52 |
| O’zgarish | -26.62% | 47.03% | 73.45% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-02-19 | 50.1% | Guggenheim | $41 → $45 | Maintains | Buy |
| 2026-02-18 | 60.11% | Needham | $46 → $48 | Maintains | Buy |
| 2026-01-21 | 56.77% | RBC Capital | $44 → $47 | Maintains | Outperform |
| 2025-12-16 | 66.78% | Stifel | $44 → $50 | Maintains | Buy |
| 2025-12-02 | 23.42% | Goldman Sachs | $30 → $37 | Maintains | Neutral |